ArticleMolecular neurobiology2025
Corticosterone-Induced Depression in Rats: Region-Specific and Time-Dependent Dysregulation of Glutamatergic Signaling, Synaptic Markers, and MMP-2 Expression.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic corticosterone (CORT) exposure in rodents is a validated model for major depressive disorder (MDD). We examined behavioral and molecular effects of repeated CORT administration and recovery in male Wistar rats. Animals received daily subcutaneous injections of CORT (40 mg/kg) or vehicle for 21 days and were evaluated immediately (CORT group) or after 7 days (CORT/RE). Behavioral assessments included the open field test (OFT), Y-maze (YM), and forced swim test (FST). Molecular analyses targeted the hippocampus and hypothalamus by RT-qPCR for Nr3c1 (GR), Nr3c2 (MR), Grin1 (NR1), and Dlg4 (PSD-95), and by immunofluorescence for NR2B, PSD-95, and MMP-2. CORT caused sustained weight loss, adrenal atrophy, and increased immobility in the FST, persisting after discontinuation without cognitive or locomotor deficits. At the molecular level, Grin1 and Dlg4 mRNA expression were reduced in the hypothalamus. NR2B protein increased in the dentate gyrus (DG) and CA3 during CORT exposure but returned to baseline after discontinuation. PSD-95 decreased in DG and CA1, with partial recovery. Notably, MMP-2 remained elevated in the dentate gyrus after CORT cessation, suggesting ongoing extracellular matrix changes that may contribute to sustained synaptic remodeling. These findings support the chronic CORT model as a paradigm of sustained depressive-like behavior and neuroplastic alterations. Persistent MMP-2 upregulation points to enduring stress-induced synaptic dysfunction, highlighting molecular features relevant to depression. Thus, this model provides a translational framework to probe HPA axis dysregulation, behavioral despair, and synaptic remodeling, paralleling key aspects of MDD.
Indexed as
Identifiers
41273623What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.